<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boero G</submitter><funding>Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill</funding><funding>NIAAA NIH HHS</funding><funding>National Institutes of Health</funding><pagination>108463</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8010646</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>186</volume><pubmed_abstract>CRF is the main activator of the hypothalamic-pituitary-adrenal (HPA) axis in response to stress. CRF neurons are found mainly in the hypothalamus, but CRF positive cells and CRF1 receptors are also found in extrahypothalamic structures, including amygdala (CeA), hippocampus, NAc and VTA. CRF release in the hypothalamus is regulated by inhibitory GABAergic interneurons and extrahypothalamic glutamatergic inputs, and disruption of this balance is found in stress-related disorders and addiction. (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP), the most potent positive modulator of GABA&lt;sub>A&lt;/sub> receptors, attenuates the stress response reducing hypothalamic CRF mRNA expression and ACTH and corticosterone serum levels. In this study, we explored 3α,5α-THP regulation of hypothalamic and extrahyp</pubmed_abstract><journal>Neuropharmacology</journal><pubmed_title>(3α,5α)3-hydroxypregnan-20-one (3α,5α-THP) regulation of hypothalamic and extrahypothalamic corticotropin releasing factor (CRF): Sexual dimorphism and brain region specificity in Sprague Dawley rats.</pubmed_title><pmcid>PMC8010646</pmcid><funding_grant_id>NIAAA-R01-AA024095</funding_grant_id><funding_grant_id>R01 AA024095</funding_grant_id><pubmed_authors>Balan I</pubmed_authors><pubmed_authors>Boero G</pubmed_authors><pubmed_authors>Todd CA</pubmed_authors><pubmed_authors>Morrow AL</pubmed_authors><pubmed_authors>O'Buckley TK</pubmed_authors><pubmed_authors>Besheer J</pubmed_authors><pubmed_authors>Tyler RE</pubmed_authors></additional><is_claimable>false</is_claimable><name>(3α,5α)3-hydroxypregnan-20-one (3α,5α-THP) regulation of hypothalamic and extrahypothalamic corticotropin releasing factor (CRF): Sexual dimorphism and brain region specificity in Sprague Dawley rats.</name><description>CRF is the main activator of the hypothalamic-pituitary-adrenal (HPA) axis in response to stress. CRF neurons are found mainly in the hypothalamus, but CRF positive cells and CRF1 receptors are also found in extrahypothalamic structures, including amygdala (CeA), hippocampus, NAc and VTA. CRF release in the hypothalamus is regulated by inhibitory GABAergic interneurons and extrahypothalamic glutamatergic inputs, and disruption of this balance is found in stress-related disorders and addiction. (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP), the most potent positive modulator of GABA&lt;sub>A&lt;/sub> receptors, attenuates the stress response reducing hypothalamic CRF mRNA expression and ACTH and corticosterone serum levels. In this study, we explored 3α,5α-THP regulation of hypothalamic and extrahyp</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T10:16:05.085Z</modification><creation>2025-04-04T10:16:05.085Z</creation></dates><accession>S-EPMC8010646</accession><cross_references><pubmed>33460689</pubmed><doi>10.1016/j.neuropharm.2021.108463</doi></cross_references></HashMap>